J. Lindebjerg

发表

miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy

B. Nielsen, K. Knudsen, J. Lindebjerg, 2018, Clinical & Experimental Metastasis.

MSH6 Mutations are Frequent in Hereditary Nonpolyposis Colorectal Cancer Families With Normal pMSH6 Expression as Detected by Immunohistochemistry

J. Lindebjerg, I. Bernstein, L. Sunde, 2012, Applied immunohistochemistry & molecular morphology : AIMM.

DPD is a molecular determinant of capecitabine efficacy in colorectal cancer.

J. Lindebjerg, K. Danenberg, P. Danenberg, 2007, International journal of oncology.

J. Lindebjerg, A. Jakobsen, N. Pallisgaard, 2011, BMC Cancer.

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer

J. Lindebjerg, T. Hansen, L. Jensen, 2020, Therapeutic advances in medical oncology.

Ultrasound elastography in patients with rectal cancer treated with chemoradiation.

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2013, European journal of radiology.

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

J. Lindebjerg, L. Jensen, A. Jakobsen, 2018, Journal of experimental & clinical cancer research : CR.

The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer

J. Lindebjerg, L. Jensen, A. Jakobsen, 2017, Cancer medicine.

Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort

J. Lindebjerg, E. Lynge, Ole Andersen, 2016, BMJ open gastroenterology.

Clinical Investigation : Gastrointestinal Cancer Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer : A Randomized Trial Comparing Two Radiation Doses

J. Lindebjerg, T. Vuong, A. Jakobsen, 2022 .

Transrectal ultrasonography and magnetic resonance imaging in the staging of rectal cancer. Effect of experience

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2008, Scandinavian journal of gastroenterology.

Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency

J. Lindebjerg, S. Kolvraa, L. Jensen, 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

The dose-effect relationship in preoperative chemoradiation of locally advanced rectal cancer: Preliminary results of a phase III trial.

J. Lindebjerg, T. Vuong, A. Jakobsen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer.

J. Lindebjerg, A. Jakobsen, R. Andersen, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long‐course preoperative chemoradiotherapy

J. Lindebjerg, A. Jakobsen, K. Spindler, 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer.

J. Lindebjerg, T. Hansen, L. Jensen, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Germline Polymorphisms may Act as Predictors of Response to Preoperative Chemoradiation in Locally Advanced T3 Rectal Tumors

J. Lindebjerg, A. Jakobsen, J. Nielsen, 2007, Diseases of the colon and rectum.

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

J. Lindebjerg, F. B. Sørensen, H. Hager, 2019, BMC Cancer.

Syddansk Universitet The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer

J. Lindebjerg, F. B. Sørensen, H. Hager, 2018 .

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

J. Lindebjerg, F. B. Sørensen, H. Hager, 2018, International Journal of Colorectal Disease.

A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis

M. Mann, E. Lengyel, J. Lindebjerg, 2020, The Journal of pathology.

Molecular screening for Lynch syndrome: from bench to bedside.

J. Lindebjerg, S. Kolvraa, L. Jensen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer.

J. Lindebjerg, T. Hansen, L. Jensen, 2019, JCO precision oncology.

Immunohistological expression of HIF‐1α, GLUT‐1, Bcl‐2 and Ki‐67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer

J. Lindebjerg, F. B. Sørensen, A. Jakobsen, 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Tumor–stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy

J. Lindebjerg, F. B. Sørensen, T. Hansen, 2017, Acta oncologica.

Long‐term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort

J. Lindebjerg, E. Lynge, Ole Andersen, 2017, International journal of cancer.

Factors influencing reproducibility of tumour regression grading after high‐dose chemoradiation of locally advanced rectal cancer

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2011, Histopathology.

Long-term patient-reported outcomes after high-dose chemoradiotherapy for non-surgical management of distal rectal cancer.

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2019, International journal of radiation oncology, biology, physics.

University of Southern Denmark Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer Dizdarevic,

J. Lindebjerg, T. Hansen, Jakobsen, 2019 .

The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer

I. Brandslund, J. Lindebjerg, T. Hansen, 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Histiocytic disorders of the gastrointestinal tract.

J. Lindebjerg, F. B. Sørensen, N. Marcussen, 2013, Human pathology.

Colorectal cancers detected through screening are associated with lower stages and improved survival.

J. Lindebjerg, M. Osler, C. Bisgaard, 2014, Danish medical journal.

The impact of mismatch repair status to the preoperative staging of colon cancer: implications for clinical management

J. Lindebjerg, T. Hansen, L. Jensen, 2020, Colorectal Cancer.

Polyposis and early cancer in a patient with low penetrant mutations in MSH6 and APC: hereditary colorectal cancer as a polygenic trait

J. Lindebjerg, L. Sunde, H. Okkels, 2006, International Journal of Colorectal Disease.

Progress in pathology Histiocytic disorders of the gastrointestinal tract

J. Lindebjerg, F. B. Sørensen, N. Marcussen, 2013 .

A streamlined mass spectrometry-based proteomics workflow for large scale FFPE tissue analysis

Matthias Mann, M. Mann, E. Lengyel, 2019, bioRxiv.

A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2008, International Journal of Colorectal Disease.

Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal

J. Lindebjerg, T. Hansen, E. Dizdarevic, 2020 .

Protein kinase C-beta II (PKC-βII) expression in patients with colorectal cancer

J. Lindebjerg, A. Jakobsen, M. Lahn, 2009, International Journal of Colorectal Disease.

Action of matrix metalloproteinases at restricted sites in colon anastomosis repair: an immunohistochemical and biochemical study.

J. Lindebjerg, J. Delaissé, T. L. Andersen, 2006, Surgery.

Virtual microscopy: an evaluation of its validity and diagnostic performance in routine histologic diagnosis of skin tumors.

Patricia Switten Nielsen, J. Lindebjerg, H. Starklint, 2010, Human pathology.

Comprehensive Analysis of DNA Methylation and Prediction of Response to NeoadjuvantTherapy in Locally Advanced Rectal Cancer

J. Lindebjerg, J. Baumbach, C. Scapulatempo-Neto, 2020, Cancers.

University of Southern Denmark Comprehensive analysis of DNA methylation and prediction of response to neoadjuvanttherapy in locally advanced rectal cancer Canto,

J. Lindebjerg, J. Baumbach, C. Scapulatempo-Neto, 2020 .

microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution

B. Nielsen, K. Knudsen, J. Lindebjerg, 2015, PloS one.

The Association between Mutations Detected in Tissue and Plasma from Patients with Colorectal Adenoma and Adenocarcinoma

H. Nielsen, J. Lindebjerg, A. Jakobsen, 2014 .

Identification of chromosome aberrations in sporadic microsatellite stable and unstable colorectal cancers using array comparative genomic hybridization.

Jun Yu Li, L. Bolund, J. Lindebjerg, 2011, Cancer genetics.

Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study

J. Lindebjerg, K. Danenberg, P. Danenberg, 2013, Cellular Oncology.

Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study

Lars Henrik Jensen, J. Lindebjerg, K. Danenberg, 2013, Cellular Oncology.

Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.

I. Brandslund, J. Lindebjerg, A. Jakobsen, 2006, International journal of radiation oncology, biology, physics.

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts

J. Lindebjerg, F. B. Sørensen, T. Hansen, 2018, British Journal of Cancer.

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

J. Lindebjerg, F. B. Sørensen, H. Hager, 2019, BMC Cancer.

[Primary adenocarcinoma in appendiceal diverticulitis].

J. Lindebjerg, J. Thomsen, N. al-Suliman, 2000, Ugeskrift for laeger.

A 3-weekly schedule of irinotecan and panitumumab for wild-type KRAS metastatic colorectal cancer

J. Lindebjerg, F. B. Sørensen, T. Hansen, 2014 .

MicroRNA-200b is downregulated in colon cancer budding cells

B. Nielsen, K. Knudsen, J. Lindebjerg, 2017, PloS one.

Intracorporeal anastomosis in right hemicolectomy for colon cancer: short-term outcomes with the DaVinci Xi robot

J. Lindebjerg, J. Andersen, H. Rahr, 2021, Journal of Robotic Surgery.

Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations

J. Lindebjerg, T. Hansen, L. Jensen, 2021, International journal of cancer.

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer

J. Lindebjerg, T. Hansen, L. Jensen, 2019, Cancers.

High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer

J. Stenvang, N. Brünner, T. Ørntoft, 2013, Molecular oncology.

The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study1

J. Lindebjerg, F. B. Sørensen, H. Hager, 2018, Translational oncology.

Limitations of tissue micro array in Duke's B colon cancer

N. Brünner, J. Lindebjerg, A. Jakobsen, 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer

I. Brandslund, J. Lindebjerg, F. B. Sørensen, 2010, Virchows Archiv.

Interobserver variability in the evaluation of mismatch repair protein immunostaining.

J. Lindebjerg, I. Bernstein, S. Ladelund, 2010, Human Pathology.

Co-Detection of miR-21 and TNF-α mRNA in Budding Cancer Cells in Colorectal Cancer

B. Nielsen, J. Lindebjerg, F. B. Sørensen, 2019, International journal of molecular sciences.

University of Southern Denmark Co-detection of miR-21 and TNF-α mRNA in budding cancer cells in colorectal cancer

B. Nielsen, J. Lindebjerg, F. B. Sørensen, 2019 .

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort

T. Blondal, J. Lindebjerg, F. B. Sørensen, 2014, British Journal of Cancer.

The Prognostic Value of Haplotypes in the Vascular Endothelial Growth Factor A Gene in Colorectal Cancer

I. Brandslund, J. Lindebjerg, S. Kolvraa, 2010, Cancers.

The importance of −460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer

I. Brandslund, J. Lindebjerg, A. Jakobsen, 2010, Journal of Cancer Research and Clinical Oncology.

Quantitative analysis of vascular endothelial growth factor receptors 1 and 2 in colorectal cancer.

I. Brandslund, J. Lindebjerg, A. Jakobsen, 2009, Molecular medicine reports.

Microsatellite Instability and the Association with Plasma Homocysteine and Thymidylate Synthase in Colorectal Cancer

I. Brandslund, J. Lindebjerg, S. Kolvraa, 2008, Cancer investigation.

Testicular microlithiasis in patients with testicular cancer in the United Kingdom and in Denmark.

J. Lindebjerg, P. Vedsted, A. Chandra, 2018, Danish medical journal.

Epidermal growth factor receptor analyses in colorectal cancer: a comparison of methods.

Ivan Brandslund, I. Brandslund, J. Lindebjerg, 2006, International journal of oncology.

Discussion: Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study.

J. Lindebjerg, C. Falster, S. Korfitzen, 2021, Canadian journal of physiology and pharmacology.

Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2006, International journal of radiation oncology, biology, physics.

Comment on "Acupuncture for Pain in Chronic Pancreatitis A Single-Blinded Randomized Crossover Trial".

J. Lindebjerg, 2020, Pancreas.

Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.

J. Lindebjerg, L. Jensen, D. Crüger, 2010, European journal of cancer.

Laser microdissection and microsatellite analysis of colorectal adenocarcinomas.

J. Lindebjerg, L. Jensen, A. Jakobsen, 2006, Anticancer research.

400MO Curative chemoradiation for low rectal cancer: Early clinical outcomes from a multicentre phase II trial

J. Lindebjerg, L. Jensen, A. Jakobsen, 2020 .

High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.

H. Harling, J. Lindebjerg, L. Jensen, 2015, The Lancet. Oncology.

Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.

J. Lindebjerg, I. Vogelius, S. Bentzen, 2014, International journal of radiation oncology, biology, physics.

Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer

J. Lindebjerg, K. Danenberg, P. Danenberg, 2011, Tumor Biology.

The prognostic importance of miR-21 in stage II colon cancer: a population-based study

B. Nielsen, J. Lindebjerg, T. Hansen, 2012, British Journal of Cancer.

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

J. Lindebjerg, F. B. Sørensen, R. dePont Christensen, 2018, Diagnostic Pathology.

Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial

J. Lindebjerg, L. Jensen, A. Jakobsen, 2015, Acta oncologica.

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort

T. Blondal, J. Lindebjerg, F. B. Sørensen, 2014, Journal of Translational Medicine.

Long‐term risk of colorectal cancer after screen‐detected adenoma: Experiences from a Danish gFOBT‐positive screening cohort

J. Lindebjerg, E. Lynge, Ole Andersen, 2020, International journal of cancer.

The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer

J. Lindebjerg, A. Bojesen, H. Rahr, 2021, Cancers.

Diagnosis of Helicobacter pylori in Bleeding Peptic Ulcer Patients, Evaluation of Urea-Based Tests

J. Lindebjerg, O. B. Schaffalitzky de Muckadell, M. Wildner-Christensen, 2002, Digestion.

Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti‐EGFR Treatment

J. Lindebjerg, T. Hansen, L. Jensen, 2019, Clinical colorectal cancer.

Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2014, Scandinavian journal of gastroenterology.

Endorectal Ultrasound Shear-Wave Elastography of Complex Rectal Adenoma and Early Rectal Cancer

J. Lindebjerg, S. Rafaelsen, M. Loft, 2022, Diagnostics.

Elastography and diffusion-weighted MRI in patients with rectal cancer.

J. Lindebjerg, A. Jakobsen, S. Rafaelsen, 2015, The British journal of radiology.

Immunohistochemistry on Frozen Section of Sentinel Lymph Nodes in Breast Cancer With Improved Morphology and Blocking of Endogenous Peroxidase

J. Lindebjerg, A. Jylling, Lone Nielsen, 2008, Applied immunohistochemistry & molecular morphology : AIMM.

miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy

B. Nielsen, K. Knudsen, J. Lindebjerg, 2018, Clinical & Experimental Metastasis.

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer

J. Lindebjerg, F. B. Sørensen, T. Hansen, 2012, BMC Cancer.

Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer.

I. Brandslund, C. Andersen, B. Nielsen, 2011, Oncology letters.

Expression of Thymidylate Synthase in Primary Colorectal Adenocarcinoma

I. Brandslund, J. Lindebjerg, A. Jakobsen, 2006, Applied immunohistochemistry & molecular morphology : AIMM.

Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population.

J. Lindebjerg, A. Jakobsen, K. Spindler, 2012, Pharmacogenomics.

The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer

I. Brandslund, J. Lindebjerg, A. Jakobsen, 2011, The Pharmacogenomics Journal.

The prognostic importance of VEGF-A haplotype combinations in stage II colon cancer, a population based study

J. Lindebjerg, A. Jakobsen, R. Andersen, 2012 .

Local staging of sigmoid colon cancer using MRI

J. Lindebjerg, L. Jensen, A. Jakobsen, 2016, Acta radiologica open.

Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.

J. Lindebjerg, F. B. Sørensen, A. Jakobsen, 2011, Anticancer research.

Proteomic profiling of colorectal adenomas identifies a predictive risk signature for development of metachronous advanced colorectal neoplasia.

N. Brünner, J. Lindebjerg, Zhaojun Zhang, 2023, Gastroenterology.

The Impact of Patient Characteristics and Tumor Biology on the Accuracy of Preoperative Staging of Colon Cancer in Denmark. A Nationwide Cohort Study

J. Lindebjerg, T. Hansen, S. Rafaelsen, 2021, Cancers.

CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study

J. Lindebjerg, T. Hansen, S. Rafaelsen, 2022, Current oncology.

Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study

J. Lindebjerg, T. Hansen, L. Jensen, 2023, Journal of Experimental & Clinical Cancer Research.

Factors of importance in procuring tumoroids from colorectal liver metastasis biopsies for precision medicine

H. Harling, J. Lindebjerg, T. Hansen, 2019, Annals of Oncology.

Predictive value of in-vitro testing anti-cancer therapy sensitivity on 3D micro-tumors (tumoroids) from patients with metastatic colorectal cancer: A feasibility study.

H. Harling, J. Lindebjerg, T. Hansen, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort

T. Blondal, J. Lindebjerg, F. B. Sørensen, 2014, Journal of Translational Medicine.

Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study

J. Lindebjerg, T. Hansen, L. Jensen, 2022, Acta oncologica.

The phenotypic spectrum of prrt2-associated paroxysmal neurologic disorders in childhood

J. Lindebjerg, J. Baumbach, C. Scapulatempo-Neto, 2020 .

Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma

J. Lindebjerg, A. Jakobsen, J. Nielsen, 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis.

J. Lindebjerg, K. Danenberg, P. Danenberg, 2006, International journal of oncology.

PET/CT and Histopathologic Response to Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer

J. Lindebjerg, A. Loft, A. Berthelsen, 2008, Diseases of the colon and rectum.

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

J. Lindebjerg, T. Hansen, L. Jensen, 2018, Journal of experimental & clinical cancer research : CR.

Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

J. Lindebjerg, T. Hansen, L. Jensen, 2019, Acta oncologica.

Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population.

J. Lindebjerg, A. Jakobsen, K. Spindler, 2012, Pharmacogenomics.

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts

J. Lindebjerg, F. B. Sørensen, T. Hansen, 2018, British Journal of Cancer.

Impact of an in-consult patient decision aid on treatment choices and outcomes of management for patients with an endoscopically resected malignant colorectal polyp: a study protocol for a non-randomised clinical phase II study

J. Lindebjerg, K. Steffensen, H. Rahr, 2023, BMJ open.

Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

J. Lindebjerg, W. Mesker, S. Landolfi, 2024, ESMO open.

Ultrasound elastography in patients with rectal cancer treated with chemoradiation.

J. Lindebjerg, S. Rafaelsen, C. Vagn-Hansen, 2013, European journal of radiology.